Blood test may forecast life-threatening clots or bleeds on ECMO

NCT ID NCT06095518

Completed Knowledge-focused Sponsor: Queen Mary Hospital, Hong Kong Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This pilot study investigates whether certain blood markers (DIC markers and thrombin generation parameters) can predict thrombotic and hemorrhagic complications in adults on ECMO life support. Researchers will observe these markers in patients with and without complications. The goal is to find early warning signs that could improve management of ECMO patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict and prevent dangerous bleeding or clotting events in patients on ECMO.
What could go wrong: This is a small pilot study with only 49 participants, so results may not apply broadly. The markers may not reliably predict complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL CIRCULATION; COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemorrhage thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EXTRACORPOREAL CIRCULATION; COMPLICATIONS EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION

Contacts and locations

Show contact details

Locations

Queen Mary Hospital

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.